retatrutide mechanism glp-1 gip glucagon triple agonist UK: New Triple-Agonist Weight Loss Injection Explained October 27, 2025: U.K. regulators

A medically supervised, affordable, results-driven weight loss program delivered 100% virtually. This virtual approach ensures you get the expert care you needa free virtual consultation and prescription services for Wegovy and Zepbound from a doctor-right from the comfort and privacy of your home

Curious About Medically Supervised Weight Loss

Many people see improvements in blood pressure, cholesterol levels, inflammation markers, and cardiovascular risk factors

The reviews found little to no difference between the drugs and placebo when looking at major cardiovascular events, mortality, or quality of life

The injectable GLP-1 medications currently on the market have published higher average weight loss figures in their landmark trials: Semaglutide (Wegovy): Demonstrated approximately 14.9% average body weight reduction in the STEP 1 trial